JPRN-UMIN000015633招募中Unknown
Assessment of efficacy and safety of PEG-IFN alpha-2a administration into patients with chronic hepatitis B on nuleoside analogue - Usefulness of PEG-IFN alpha-2a treatment in combination with nucleoside analogue
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College0 个研究点目标入组 100 人开始时间: 2023年12月31日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with advance liver fibrosis 2. Patients with other serious diseases 3. Women who are pregnant or those who have a possibility to be pregnant. 4. Patients who have a contra-indication for receiving PEG-IFN alpha-2a treatment
研究者
相似试验
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a for the treatment of chronic hepatitis B.chronic hepatitis BJPRN-UMIN000006649Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine100
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a plus Adefovir dipivoxil for the treatment of chronic hepatitis Bchronic hepatitis BJPRN-UMIN000006659Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine50
已完成
4 期
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral roadchronic hepatitis CJPRN-UMIN000001170Gunma Liver Study Group220
已完成
不适用
PEG-IFN Alpha (Injection) in Chronic Hepatitis B Patients.CTRI/2017/07/008991Institute of liver and Biliary Sciences118
已完成
4 期
Efficacy and safety of PEG-Inferon (peginterferon alpha-2b) for the treatment of chronic hepatitis C - An open-label study in India.CTRI/2011/091/000028Virchow Biotech100